Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | February 23, 2021 | February 24, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date February 23, 2021 · Filed February 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,529 |
Ending reported balance
After 2021-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-02-23 · Exercise / conversion · Acquired 3,530 · Balance 41,187 Row 2 · 2021-02-23 · Sale · Disposed 658 · Balance 40,529 F1: This transaction was executed in multiple trades at prices ranging from $281.62 to $281.79 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.29 · Expires 2021-05-07 | Direct | 0 |
Reported balance
After 2021-02-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-02-23 · Exercise / conversion · Disposed 3,530 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $281.62 to $281.79 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2021 Filed Feb 24, 2021 16:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,530 | $0.00 Strike: $52.29 | $0.00 |
DisclosureSEC source: 0001127602-21-007521 · form4.xml · derivative · entry 3 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,530 shares Expires 2021-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 16:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 658 | $281.66 | $185,330.37 |
DisclosureSEC source: 0001127602-21-007521 · form4.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,529 F1 · price: This transaction was executed in multiple trades at prices ranging from $281.62 to $281.79 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 16:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,530 | $52.29 | $184,583.70 |
DisclosureSEC source: 0001127602-21-007521 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 18:48 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $218.58 | $65,574.99 |
DisclosureSEC source: 0001127602-20-023888 · form4.xml · nonDerivative · entry 6 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,657 F2 · price: This transaction was executed in multiple trades at prices ranging from $218.46 to $218.82 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 18:48 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 700 | $217.25 | $152,075.98 |
DisclosureSEC source: 0001127602-20-023888 · form4.xml · nonDerivative · entry 5 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,957 F1 · price: This transaction was executed in multiple trades at prices ranging from $216.865 to $217.80 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 18:48 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 110 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-023888 · form4.xml · nonDerivative · entry 4 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,657 Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:48 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 460 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-023888 · form4.xml · nonDerivative · entry 3 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,767 Read SEC document |
| May 21, 2020 Filed Aug 19, 2020 18:48 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-023888 · form4.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,227 Read SEC document |
| May 20, 2020 Filed Aug 19, 2020 18:48 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-023888 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,382 Read SEC document |
| May 11, 2020 Filed May 13, 2020 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 2,539 | $0.00 Strike: $164.24 | $0.00 |
DisclosureSEC source: 0001127602-20-016371 · form4.xml · derivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539 Underlying: Common Stock · 2,539 shares Expires 2030-05-11 F2 · derivative.exercise_date: The Stock Options become exercisable upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 11, 2020 Filed May 13, 2020 14:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 741 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-016371 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,282 F1 · shares: The unvested restricted stock units vest upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 15:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,140 | $0.00 Strike: $70.29 | $0.00 |
DisclosureSEC source: 0001127602-20-008270 · form4.xml · derivative · entry 5 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,140 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 15:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,030 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001127602-20-008270 · form4.xml · derivative · entry 4 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,030 shares Expires 2020-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 15:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,464 | $160.89 | $396,437.40 |
DisclosureSEC source: 0001127602-20-008270 · form4.xml · nonDerivative · entry 3 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,541 F1 · price: This transaction was executed in multiple trades at prices ranging from $160.84 to $160.93 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 15:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,140 | $70.29 | $220,710.60 |
DisclosureSEC source: 0001127602-20-008270 · form4.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 15:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 4,030 | $43.39 | $174,861.70 |
DisclosureSEC source: 0001127602-20-008270 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2019 Filed Jan 24, 2020 13:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002314 · form5.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,835 Read SEC document |
| August 30, 2019 Filed Jan 24, 2020 13:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-002314 · form5.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,835 Read SEC document |
| May 22, 2019 Filed May 23, 2019 17:24 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019564 · form4.xml · nonDerivative · entry 3 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,325 F1 · kind: Consists of 1,882 unvested restricted stock units that vest upon the earlier of 5/22/2020, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| February 27, 2019 Filed May 23, 2019 17:24 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019564 · form4.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,443 Read SEC document |
| February 22, 2019 Filed May 23, 2019 17:24 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 705 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019564 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,623 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,540 | $0.00 Strike: $33.93 | $0.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · derivative · entry 27 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,540 shares Expires 2019-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 240 | $141.36 | $33,926.40 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 26 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,328 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.35 | $28,270.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 25 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,568 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 103 | $141.34 | $14,558.02 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 24 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,768 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.34 | $14,133.50 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 23 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,871 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.33 | $28,266.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 22 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,971 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.32 | $28,264.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 21 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,171 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.31 | $28,261.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 20 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,371 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.30 | $14,130.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 19 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,571 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 97 | $141.29 | $13,705.13 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 18 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,671 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.28 | $14,128.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 17 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,768 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $141.27 | $42,381.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 16 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,868 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.26 | $28,252.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 15 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,168 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.23 | $28,246.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 14 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,368 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $141.22 | $56,488.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 13 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,568 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 367 | $141.20 | $51,818.57 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 12 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,968 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 355 | $141.18 | $50,118.90 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 11 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,335 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 378 | $141.16 | $53,358.48 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 10 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,690 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.14 | $14,114.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 9 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,068 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.14 | $14,113.50 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 8 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,168 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.13 | $14,113.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 7 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,268 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.12 | $14,112.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 6 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,368 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.11 | $14,111.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 5 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,468 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.08 | $14,108.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 4 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,568 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.08 | $14,107.50 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 3 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,668 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.07 | $14,107.00 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,768 Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 14:14 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 4,540 | $33.93 | $154,042.20 |
DisclosureSEC source: 0001127602-19-007344 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2018 Filed Feb 1, 2019 18:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003333 · form5.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,328 Read SEC document |
| August 28, 2018 Filed Feb 1, 2019 18:05 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-003333 · form5.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,328 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.